Translational Development Acquisition Corp. TDAC
Set alert
10.82 USD -0.03 -0.28%
At close · Oct 30
10.82 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
10.81 Day range 10.84
10.41 52-week range 10.90
- YTD
- +3.15%
- 1 year
- +3.54%
- Open
- 10.82
- Prev close
- 10.85
- Mkt cap
- 208.92M
- Vol
- 18.21K
- Avg vol
- 22.43K
- EPS
- 0.26
- P/E
- 41.62
- Div yield
- 0.00%
More statistics
- Low
- 10.81
- High
- 10.84
- Forward P/E
- 378.50
- Beta
- 0.09
- Short ratio
- 6.42
- Inst. own
- 3.87%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 12.41
- 200-d avg
- 11.99
- 1y target
- 16.00
2Y chart
Signals (57)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 5 days ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| RSI: Overbought | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| RSI: Overbought | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| RSI: Overbought | Apr 6, 2026 | 6 months ago |
| RSI: Overbought | Mar 27, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 27, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| RSI: Overbought | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
| RSI: Overbought | Jan 21, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 9, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 30, 2025 | 10 months ago |
| RSI: Overbought | Dec 30, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 26, 2025 | 10 months ago |
| RSI: Overbought | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 4, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 6, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 14, 2025 | 1 year ago |
| RSI: Overbought | Oct 14, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 1, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 23, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 9, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 29, 2025 | 1 year ago |
| RSI: Overbought | Aug 28, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| RSI: Overbought | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| MACD: Buy Signal | May 21, 2025 | 1 year ago |
| RSI: Overbought | May 20, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| RSI: Overbought | May 12, 2025 | 1 year ago |
| RSI: Overbought | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| RSI: Overbought | Mar 21, 2025 | 1 year ago |
| RSI: Overbought | Mar 13, 2025 | 1 year ago |
Key statistics
- Market cap
- 181.19M
- Enterprise value
- 186.14M
- Trailing P/E
- 0.00
- Forward P/E
- 378.50
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 25.15
- EPS (TTM)
- -0.707
- Beta
- 0.09
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -1.40M
- Total cash
- 129.39K
- Total debt
- 5.08M
- Return on equity
- -108.49%
- Shares outstanding
- 11.97M
- Short % of float
- 12.94%
- 50-day average
- 12.41
- 200-day average
- 11.99
Analyst view
Consensus: buy
Buy
Price target (mean) 16.00
Next earnings
Consensus EPS estimate -2.50.
Financials — quick view
TDAC Revenue — quarterly 0
TDAC Net income — quarterly 946.98K
TDAC EPS — quarterly 0.04
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 21, 2021 | Northland Capital Markets | init | — | Outperform |
About Translational Development Acquisition Corp.
As of October 29, 2021, Trident Acquisitions Corp. was acquired by Autolotto, Inc., in a reverse merger transaction. Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector. Trident Acquisitions Corp. was incorporated in 2016 and is headquartered in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- tridentacquisitions.com
News
- ProLogium Announces Appointment of Airbus Senior Vice President Greg Ombach as Independent Director
- ProLogium Unveils DCN, Opening a “Third State” Electrolyte Universe at Paris Motor Show
- Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium's latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology
- Translational Development Acquisition Merger Partner ProLogium Receives Investment From Kyushu Electric Power
- Kyushu Electric Power Advances Strategic Investment in ProLogium, Deepening Collaboration in Next-Generation Batteries and Energy Sector
- ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
- $HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - WEAV, BRBS, TDAC and UHG
- Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC
- Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC
- ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
Your note
Sign in to keep a note on TDAC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUTKEVYCH GENNADII | Director | Purchase | Feb 3, 2020 | 0 |
| GLAZER CAPITAL, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 30, 2020 | 0 |
| HUDSON BAY CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 12, 2020 | 0 |
| HUDSON BAY CAPITAL MANAGEMENT. L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 12, 2020 | 0 |
| KOMISSAROV VADIM | President | Conversion of Exercise of derivative security | Jun 3, 2018 | 324,860 |
| PONOMAREV ILYA | Director | Sale | May 2, 2021 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Royce & Associates LP | 1.60% | 192,000 | 2.42M | Jun 29, 2021 |
| First Wilshire Securities Management Inc | 0.58% | 70,000 | 884.10K | Jun 29, 2021 |
| Millennium Management LLC | 0.39% | 46,407 | 586.12K | Jun 29, 2021 |
| HRT Financial LLC | 0.25% | 30,352 | 383.35K | Jun 29, 2021 |
| MYDA Advisors LLC | 0.25% | 30,000 | 378.90K | Jun 29, 2021 |
| B. Riley Wealth Management, Inc. | 0.16% | 18,700 | 236.18K | Jun 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Royce Smaller Companies Growth Fund | 1.60% | 192,000 | 2.42M | Jun 29, 2021 |
| Fidelity NASDAQ Composite Index Fund | 0.10% | 12,219 | 142.11K | Aug 30, 2021 |